ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

NCI advisors approve new grants programs. NCI funds consortium of cohorts. Funding opportunities listed.

August 1, 2003

In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says

April 13, 1979

NCI Awards 41.5 Million for DES Study

February 28, 1975

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991